Petros Pharma Faces Delisting Concerns
Ticker: PTPI · Form: 8-K · Filed: May 21, 2025 · CIK: 1815903
| Field | Detail |
|---|---|
| Company | Petros Pharmaceuticals, Inc. (PTPI) |
| Form Type | 8-K |
| Filed Date | May 21, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, compliance, stock-exchange
TL;DR
Petros Pharma might get delisted, check exchange rules.
AI Summary
Petros Pharmaceuticals, Inc. filed an 8-K on May 21, 2025, to report a notice of delisting or failure to satisfy a continued listing rule or standard. The company is based in New York, NY, and its principal executive offices are located at 1185 Avenue of the Americas, 3rd Floor.
Why It Matters
This filing indicates potential issues with Petros Pharmaceuticals' compliance with stock exchange listing requirements, which could impact its stock's tradability and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading status and investor confidence.
Key Players & Entities
- Petros Pharmaceuticals, Inc. (company) — Registrant
- May 20, 2025 (date) — Earliest event reported
- May 21, 2025 (date) — Date of report
- 1185 Avenue of the Americas, 3rd Floor (location) — Principal executive offices
- New York, New York (location) — City, State of principal executive offices
FAQ
What specific listing rule or standard has Petros Pharmaceuticals, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that Petros Pharmaceuticals, Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is May 20, 2025.
What is the Commission File Number for Petros Pharmaceuticals, Inc.?
The Commission File Number for Petros Pharmaceuticals, Inc. is 001-39752.
Where are the principal executive offices of Petros Pharmaceuticals, Inc. located?
The principal executive offices of Petros Pharmaceuticals, Inc. are located at 1185 Avenue of the Americas, 3rd Floor, New York, New York 10036.
What is the Standard Industrial Classification (SIC) code for Petros Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code for Petros Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 21, 2025 regarding Petros Pharmaceuticals, Inc. (PTPI).